Instrument Inactif

Communiqués Generex Biotechnology Corporation OTC Bulletin Board

Actions

US3714851033

Cours en clôture OTC Bulletin Board Autres places de cotation
- ^USD	-

2022	Requête involontaire approuvée pour Generex Biotechnology Corporation	CI
2022	Pétition involontaire déposée contre Generex Biotechnology Corporation	CI

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Generex Biotechnology Corporation : Subsidiary, Olaregen Therapeutix Announces its Malaysian Distribution Partner, Nexgen Medical, has gained approval for the use of Excellagen® Wound Conforming Matrix from The Malaysian Ministry of Health, its country’s equivalent to the U.S. FDA	26/07/21	AQ
Generex Biotechnology : Material Event (Form 8-K)	23/07/21	PU
GENEREX BIOTECHNOLOGY CORP : Other Events (form 8-K)	23/07/21	AQ
Generex Biotechnology : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. Unregistered Sales of Equity Securities (Form 8-K)	21/07/21	PU
GENEREX BIOTECHNOLOGY CORP : Unregistered Sale of Equity Securities (form 8-K)	21/07/21	AQ
NuGenerex Immuno-Oncology Secures $535 Million Valuation from World-Class Independent Valuation & Appraisal Firm	22/06/21	GL
GENEREX BIOTECHNOLOGY : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	21/06/21	AQ
GENEREX BIOTECHNOLOGY CORP : Other Events (form 8-K)	12/05/21	AQ
Generex Biotechnology : Subsidiary NuGenHealth Contracts with Westside Medicine & Cardiology, Inc. to Provide Remote Patient Monitoring (RPM) Services	11/05/21	AQ
Generex Posts Recording of May 6 Shareholder Conference Call Highlighting its Ii-Key COVID Complete Vaccine™ and its Go-Forward Plans for Revenue Producing Assets	10/05/21	GL
Generex Biotechnology : Subsidiary NuGenHealth Contracts with Florida Health Care Associates to Provide Remote Patient Monitoring (RPM) Services	06/05/21	AQ
Generex Provides Clarification on Its Ii-Key COVID-19 Complete Vaccine China Partnership Agreement	05/05/21	GL
Generex Biotechnology Announces Call-in Details and Agenda for Shareholder Conference Call on Thursday May 6, 2021 at 9:00 AM	04/05/21	GL
Generex Biotechnology : Subsidiary Olaregen Therapeutix Announces Agreement with Nexgen Medical for Distribution of Excellagen® Wound Conforming Matrix in Malaysia	03/05/21	AQ
Generex Biotechnology : Title of each class Trading Symbol(s) Name of each exchange on which registered	29/04/21	PU
GENEREX BIOTECHNOLOGY CORP : Other Events (form 8-K)	29/04/21	AQ
GENEREX BIOTECHNOLOGY CORP : Other Events (form 8-K)	27/04/21	AQ
Generex Provides Update on its Ii-Key COVID-19 Complete Vaccine Program: Advancing Global Development	27/04/21	AQ
Generex Biotechnology : NuGenerex Immuno-Oncology Submits Protocol, Data, and Manufacturing Information to FDA in Advance of the IND Submission	12/04/21	AQ
Generex Biotechnology : Last Chance for Children is Proud to Announce its Partnership with Generex Biotechnology & NuGenerex Immuno-Oncology to SAFELY and EFFECTIVELY Vaccinate Children and Pregnant Women	08/04/21	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Generex Biotechnology Corporation OTC Bulletin Board

Actions

US3714851033

Communiqués

Filtres